Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities

Recombinant human erythropoietin (rhEPO) is receiving increasing attention as a potential therapy for prevention of injury and restoration of function in nonhematopoietic tissues. However, the minimum effective dose required to mimic and augment these normal paracrine functions of erythropoietin (EP...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Coleman, Thomas R., Westenfelder, Christof, Tögel, Florian E., Yang, Ying, Hu, Zhuma, Swenson, LeAnne, Leuvenink, Henri G. D., Ploeg, Rutger J., d’Uscio, Livius V., Katusic, Zvonimir S., Ghezzi, Pietro, Zanetti, Adriana, Kaushansky, Kenneth, Fox, Norma E., Cerami, Anthony, Brines, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2006
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1458681/
https://ncbi.nlm.nih.gov/pubmed/16585502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0601377103
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados